Inmagene Biopharmaceuticals closed $21 million Series B financing, making the total raised to date over $40 million ...Middle East

PR Newswire - News
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), announced today that it had closed a $21 million Series B financing, led by Vertex Ventures China, and co-invested by Panacea Venture, Kunlun Capital, SCVC and a few other investors. The Series B financing...

Read More Details
Finally We wish PressBee provided you with enough information of ( Inmagene Biopharmaceuticals closed $21 million Series B financing, making the total raised to date over $40 million )

Apple Storegoogle play

Also on site :